CPT codes

55081 CPT codes with hospital pricing data in the network.

• CPT 0488U — OB FETAL AG NIPT CFDNA ALYS (353 hospitals, — samples)
• CPT 0489T — Autologous adipose-derived regenerative cell therapy for scleroderma in the hands; adipose tissue harvesting, isolation and preparation of harvested cells including incubation with cell dissociation e (322 hospitals, — samples)
• CPT 0489U — Obstetrics (single gene noninvasive prenatal test), cell-free DNA sequence analysis of 1 or more targets to identify paternally inherited pathogenic variants, and relative mutation-dosage analysis bas (198 hospitals, — samples)
• CPT 0490T — REGN CELL TX SCLDR H MLT INJ (323 hospitals, — samples)
• CPT 0490U — ONC CUTAN/UVEAL MLNMA CD146 (378 hospitals, — samples)
• CPT 0491T — ABLATIVE LASER TREATMENT, NON-CONTACT, FULL FIELD AND FRACTIONAL ABLATION, OPEN WOUND, PER DAY, TOTAL TREATMENT SURFACE AREA; FIRST 20 SQ CM OR LESS (94 hospitals, — samples)
• CPT 0491U — ONC SOL TUM CTC SLCT ER PRTN (377 hospitals, — samples)
• CPT 0492T — Abl lsr opn wnd addl 20 sqcm (66 hospitals, — samples)
• CPT 0492U — ONC SOL TUM CTC SLCTN PD-L1 (377 hospitals, — samples)
• CPT 0493U — Transplantation medicine, quantification of donor-derived cell-free DNA (cfDNA) using next-generation sequencing, plasma, reported as percentage of donor-derived cell-free DNA (377 hospitals, — samples)
• CPT 0494T — Prep & cannulj cdvr don lung (338 hospitals, — samples)
• CPT 0494U — RBC AG FTL RHD GENE ALYS NGS (377 hospitals, — samples)
• CPT 0495T — INIT & MNTR CDVR DON LNG ORGN PRFUJ SYS 1ST 2 HR (338 hospitals, — samples)
• CPT 0495U — Oncology (prostate), analysis of circulating plasma proteins (tPSA, fPSA, KLK2, PSP94 and GDF15), germline polygenic risk score (60 variants), clinical information (age, family history of prostate can (388 hospitals, — samples)
• CPT 0496T — Initiation and monitoring marginal (extended) cadaver donor lung(s) organ perfusion system by physician or qualified health care professional, including physiological and laboratory assessment (eg, pu (338 hospitals, — samples)
• CPT 0496U — Oncology (colorectal), cell-free DNA, 8 genes for mutations, 7 genes for methylation by real-time RT-PCR, and 4 proteins by enzyme-linked immunosorbent assay, blood, reported positive or negative for (220 hospitals, — samples)
• CPT 0497U — Onc prst8 mrna rt-pcr 6genes (377 hospitals, — samples)
• CPT 0498U — Oncology (colorectal), next-generation seequencing for mutation detection in 43 genes and methylation pattern in 45 genes, blood and formalin-fixed paraffin-embedded (FFPE) tissue, report of variants (209 hospitals, — samples)
• CPT 0499T — Fee Schedule (191 hospitals, — samples)
• CPT 0499U — Onc clrct&lng dna ngs 8genes (377 hospitals, — samples)
• CPT 0500U — Autoinflam ds vexas synd dna (379 hospitals, — samples)
• CPT 0501U — Oncology (colorectal), blood, quantitative measurement of cell-free DNA (cfDNA) (198 hospitals, — samples)
• CPT 0502U — Human papillomavirus (HPC), E6/E7 markers for high-risk types (16,18,31,33,35,39,45,51,52,56,58,59,66 and 68), cervical cells, branched-chain capture hybridization, reported as negative or positive fo (377 hospitals, — samples)
• CPT 0504U — Nfct ds uti id 17 path orgs (377 hospitals, — samples)
• CPT 0505U — NFCT DS VAG INFCTJ ID 32ORGS (386 hospitals, — samples)
• CPT 0506U — GI BARRETTS ESOPHGL CELL 89 (378 hospitals, — samples)
• CPT 0507U — Oncology (ovarian), DNA, whole-genome sequencing with 5-hydroxymethylcytosine (5hmC) enrichment, using whole blood or plasma, algorithm reported as cancer detected or not detected (377 hospitals, — samples)
• CPT 0510T — RMVL SINUS TARSI IMPLANT (421 hospitals, — samples)
• CPT 0510U — Augmentative algorithmic analysis of 16 genes using previously sequenced RNA (212 hospitals, — samples)
• CPT 0511T — Rmvl&rinsj sinus tarsi implt (418 hospitals, — samples)
• CPT 0511U — ONC SOL TUM 3DMICROENVIR 36+ (377 hospitals, — samples)
• CPT 0512T — HC Esw Integ Wnd Hlg Ini Wnd (427 hospitals, — samples)
• CPT 0512U — Onc prst8 alys dgtz img msi (388 hospitals, — samples)
• CPT 0513T — ESW INTEG WND HLG EA ADDL (323 hospitals, — samples)
• CPT 0513U — Oncology (prostate), augmentative algorighmic analysis of digitized whole-slide imaging of histologic features for microsatellite instability (MSI) and homologous recombination deficience (HRD) status (388 hospitals, — samples)
• CPT 0514U — Gastroenterology (irritable bowel disease (IBD), immunoassay for quantitative determination of adalimumab (ADL) levels in venous serum in patients undergoing adalimumab therapy, results reported as a (378 hospitals, — samples)
• CPT 0515U — GI IBD IA QUAN DETER IFX LVL (378 hospitals, — samples)
• CPT 0516U — RX METAB RXGENOMIC GNOTYP 40 (377 hospitals, — samples)
• CPT 0517U — THER RX MNTR 80+ PSYACTIV RX (377 hospitals, — samples)
• CPT 0518U — Therapeutic drug monitoring, 90 or more pain and mental health drugs or substances, LC-MS/MS, plasma, qualitative and quantitative therpeutic minimally effective range of prescribed and non-prescribed (377 hospitals, — samples)
• CPT 0519U — Therapeutic drug monitoring, medications specific to pain, depression, and anxiety, LC-MS/MS, plasma, 110 or more drugs or substances, qualitative and quantitative therpeutic minimally effective range (377 hospitals, — samples)
• CPT 0520U — Ther rx mntr 200+ rx/sbsts (377 hospitals, — samples)
• CPT 0532U — Rare diseases (constitutional disease/hereditary disorders), rapid whole genome and mitochondrial DNA sequencing for single-nucleotide variants, insertions/deletions, copy number variations (206 hospitals, — samples)
• CPT 0533U — Drug metabolism (adverse drug reactions and drug response), genotyping of 16 genes (ie, ABCG2, CYP2B6, CYP2C9, CYP2C19, CYP2C, CYP2D6, CYP3A5, CYP4F2, DPYD, G6PD, GGCX, NUDT15, SLCO1B1, TPMT, (215 hospitals, — samples)
• CPT 0535U — Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), by liquid chromatography with tandem mass spectrometry (LC-MS/MS), plasma or serum, quantitative (198 hospitals, — samples)
• CPT 0536U — Red blood cell antigen (fetal RhD), PCR analysis of exon 4 of RHD gene and housekeeping control gene GAPDH from whole blood in pregnant individuals at 10+ weeks gestation (206 hospitals, — samples)
• CPT 0537U — ONC CLRCT CA CFDNA >2500 DMR (322 hospitals, — samples)
• CPT 0538T — Bld drv t lymphcyt prep trns (92 hospitals, — samples)
• CPT 0538U — ONC SOL TUM NGTS FFPE 600GEN (215 hospitals, — samples)
• CPT 0539T — Receipt&prep car-t cll admn (93 hospitals, — samples)